• Move 2 Improve

Publicaties

A clinical decision framework for the identification of main problems and treatment goals for ambulant children with bilateral spastic cerebral palsy. Franki I, De Cat J, Deschepper E, Molenaers G, Desloovere K, Himpens E, Vanderstraeten G, Van den Broeck C. Res Dev Disabil. 2014 May;35(5):1160-76.

Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy? Bar-On L, Van Campenhout A, Desloovere K, Aertbeliën E, Huenaerts C, Vandendoorent B, Nieuwenhuys A, Molenaers G. Arch Phys Med Rehabil. 2014 Mar;95(3):515-23.

Botulinum toxin A treatment of the lower extremities in children with cerebral palsy. Molenaers G, Fagard K, Van Campenhout A, Desloovere K. J Child Orthop. 2013 Nov;7(5):383-7. doi: 10.1007/s11832-013-0511-x. Epub 2013 Aug 28. Review.

Lower limb functioning and its impact on quality of life in ambulatory children with cerebral palsy. Jaspers E, Verhaegen A, Geens F, Van Campenhout A, Desloovere K, Molenaers G. Eur J Paediatr Neurol. 2013 Nov;17(6):561-7.

Randomized trial of modified constraint-induced movement therapy with and without an intensive therapy program in children with unilateral cerebral palsy. Klingels K, Feys H, Molenaers G, Verbeke G, Van Daele S, Hoskens J, Desloovere K, De Cock P. Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):799-807.

Comprehensive quantification of the spastic catch in children with cerebral palsy. Lynn BO, Erwin A, Guy M, Herman B, Davide M, Ellen J, Anne C, Kaat D. Res Dev Disabil. 2013 Jan;34(1):386-96.

The evidence-base for conceptual approaches and additional therapies targeting lower limb function in children with cerebral palsy: a systematic review using the ICF as a framework. Franki I, Desloovere K, De Cat J, Feys H, Molenaers G, Calders P, Vanderstraeten G, Himpens E, Van Broeck C. J Rehabil Med. 2012 May;44(5):396-405.

Arm and hand function in children with unilateral cerebral palsy: a one-year follow-up study. Klingels K, Feys H, De Wit L, Jaspers E, Van de Winckel A, Verbeke G, De Cock P, Molenaers G. Eur J Paediatr Neurol. 2012 May;16(3):257-65.

Botulinum toxin type A treatment in children with cerebral palsy: evaluation of treatment success or failure by means of goal attainment scaling. Desloovere K, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Molenaers G. Eur J Paediatr Neurol. 2012 May;16(3):229-36.

Three-dimensional upper limb movement characteristics in children with hemiplegic cerebral palsy and typically developing children. Jaspers E, Desloovere K, Bruyninckx H, Klingels K, Molenaers G, Aertbeliën E, Van Gestel L, Feys H. Res Dev Disabil. 2011 Nov-Dec;32(6):2283-94.

The effect of different physiotherapy interventions in post-BTX-A treatment of children with cerebral palsy. Desloovere K, De Cat J, Molenaers G, Franki I, Himpens E, Van Waelvelde H, Fagard K, Van den Broeck C. Eur J Paediatr Neurol. 2011 Sep 23.

Botulinum toxin type A treatment in children with cerebral palsy: evaluation of treatment success or failure by means of goal attainment scaling. Desloovere K, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Molenaers G. Eur J Paediatr Neurol. 2011 Aug 13.

The Arm Profile Score: A new summary index to assess upper limb movement pathology. Jaspers E, Feys H, Bruyninckx H, Klingels K, Molenaers G, Desloovere K. Gait Posture. 2011 Jun;34(2):227-33.

Arm swing during walking at different speeds in children with Cerebral Palsy and typically developing children. Meyns P, Van Gestel L, Massaad F, Desloovere K, Molenaers G, Duysens J. Res Dev Disabil. 2011 Sep-Oct;32(5):1957-64. Epub 2011 May 4.

Upper limb kinematics: development and reliability of a clinical protocol for children. Jaspers E, Feys H, Bruyninckx H, Harlaar J, Molenaers G, Desloovere K. Gait Posture. 2011 Feb;33(2):279-85. Epub 2010 Dec 31.

Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin. Van Campenhout A, Molenaers G. Dev Med Child Neurol. 2011 Feb;53(2):108-19. Epub 2010 Oct 21. Review.

The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. Molenaers G, Van Campenhout A, Fagard K, De Cat J, Desloovere K. J Child Orthop. 2010 Jun;4(3):183-95. Epub 2010 Mar 18.

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Heinen F, Desloovere K, Schroeder AS, Berweck S, et al. Eur J Paediatr Neurol. 2010 Jan14(1):45-66. Epub 2009 Nov 14. Review.

Review of quantitative measurements of upper limb movements in hemiplegic cerebral palsy. Jaspers E, Desloovere K, Bruyninckx H, Molenaers G, Klingels K, Feys H. Gait Posture. 2009 Nov30(4):395-404. Epub 2009 Aug 12. Review.

Bilateral patellar Köhler's disease in an eleven-year-old child with growth retardation: a case report. Corten K, Vandenneucker H, Molenaers G, Bellemans J, Moens P. Acta Orthop Belg. 2009 Apr75(2):273-6.PMID: 19492571

Relation between neuroradiological findings and upper limb function in hemiplegic cerebral palsy. Feys H, Eyssen M, Jaspers E, Klingels K, Desloovere K, Molenaers G, De Cock P. Eur J Paediatr Neurol. 2010 Mar14(2):169-77. Epub 2009 Mar 9.

Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency. Molenaers G, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Desloovere K. Eur J Paediatr Neurol. 2009 Sep13(5):421-9. Epub 2008 Nov 1.

8 keer bekeken
Contacteer ons !

 

​VZW Move To Improve
Sint-Maartenstraat 53
B-3770 Genoelselderen

 

0484/75.36.07

BE 0808.300.505

Volg ons op sociale media !
  • Facebook Clean Grey